Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT02030691
NA

Tolerance of nHFPV Versus nCPAP in Neonatal Respiratory Distress

Sponsor: University Hospital, Bordeaux

View on ClinicalTrials.gov

Summary

Respiratory distress is the main cause of morbimortality in preterm and term neonates. In most of the case, these babies required the use of positive end expiratory pressure (PEEP) delivered by a non invasive device. Nasal continuous airway positive pressure (nCPAP) is widely used in neonatal intensive care unit. Nasal high frequency percussive ventilation (nHFPV) can be used as non invasive device to deliver PEEP, and improved lung clearance. We hypothesized that nHFPV can be used to deliver PEEP in preterm and term newborn with respiratory distress with the same tolerance as nCPAP. To compare the tolerance of these devices we used cerebral tissue oxygenation (rSO2c) measured by near infrared spectroscopy (NIRS).

Official title: Tolerance of Nasal High Frequency Percussive Ventilation Versus Nasal CPAP in Neonatal Respiratory Distress in Term and Preterm (> 33 Weeks of Gestation) Neonates

Key Details

Gender

All

Age Range

Any - 30 Minutes

Study Type

INTERVENTIONAL

Enrollment

49

Start Date

2014-05

Completion Date

2016-11-07

Last Updated

2026-05-28

Healthy Volunteers

No

Interventions

DEVICE

Nasal continuous airway positive pressure (nCPAP)

DEVICE

Nasal high frequency percussive ventilation (nHFPV)

Locations (1)

Service de Néonatalogie - Maternité - Hôpital Pellegrin

Bordeaux, Bordeaux, France